MedTrace Logo

A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer

NCT01237171 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-03-30

No results posted yet for this study

Summary

For patients diagnosed with early (Stage I) non-small cell lung cancer, a lobe of lung is usually removed at surgery to treat the cancer. For some patients, the removal of a lobe of lung may leave too little lung behind for easy breathing. For some of these patients, it may be possible to perform a smaller-scale surgery ("sub-lobar resection") and place a radioactive implant behind to prevent the cancer from growing back. This study will see how these patients do in terms of controlling their disease treated with a radioactive implant called Cesium-131.

Conditions

  • NSCLC
  • Non Small Cell Lung Cancer

Interventions

RADIATION

Cesium-131 Brachytherapy Seed

85 Gray Dose

Sponsors & Collaborators

  • IsoRay Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Bhupesh Parashar, M.D. · Weill Medical College of Cornell University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01237171 on ClinicalTrials.gov